These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36545254)

  • 1. Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors.
    Tran BT; Gelin A; Durand S; Texier M; Daste A; Toullec C; Benihoud K; Breuskin I; Gorphe P; Garic F; Brenner C; Le Tourneau C; Fayette J; Niki T; David M; Busson P; Even C
    Oncoimmunology; 2023; 12(1):2150472. PubMed ID: 36545254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 Expression in High-Risk HPV-Positive and Negative Head & Neck Squamous Cell Carcinomas and Regional Lymph Node Metastases.
    Coppock JD; Mills AM; Stelow EB
    Head Neck Pathol; 2021 Mar; 15(1):163-168. PubMed ID: 32564273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas in northern Spain.
    Rodrigo JP; Hermsen MA; Fresno MF; Brakenhoff RH; García-Velasco F; Snijders PJ; Heideman DA; García-Pedrero JM
    Cancer Epidemiol; 2015 Feb; 39(1):37-41. PubMed ID: 25468644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan.
    Deng Z; Hasegawa M; Matayoshi S; Kiyuna A; Yamashita Y; Maeda H; Suzuki M
    Eur Arch Otorhinolaryngol; 2011 Nov; 268(11):1625-31. PubMed ID: 21328000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
    Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
    Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Immunology and HPV.
    Wollenberg B
    Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas.
    Dahm V; Haitel A; Kaider A; Stanisz I; Beer A; Lill C
    Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1837-1843. PubMed ID: 29744637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
    Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
    Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.
    Payabvash S; Chan A; Jabehdar Maralani P; Malhotra A
    Neuroradiol J; 2019 Aug; 32(4):232-240. PubMed ID: 31084347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas?
    Cada Z; Chovanec M; Smetana K; Betka J; Lacina L; Plzák J; Kodet R; Stork J; Lensch M; Kaltner H; André S; Gabius HJ
    Histol Histopathol; 2009 Jan; 24(1):41-8. PubMed ID: 19012243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
    Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated overview of HPV-associated head and neck carcinomas.
    Zaravinos A
    Oncotarget; 2014 Jun; 5(12):3956-69. PubMed ID: 24970795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary lung malignancy following head and neck squamous cell carcinoma.
    Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
    Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.
    Maruyama H; Yasui T; Ishikawa-Fujiwara T; Morii E; Yamamoto Y; Yoshii T; Takenaka Y; Nakahara S; Todo T; Hongyo T; Inohara H
    Cancer Sci; 2014 Apr; 105(4):409-17. PubMed ID: 24521534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
    Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
    JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.